Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte nuclear factor 4 gamma pseudogene 1 (HNF4GP1) is a genomic DNA sequence with high similarity to hepatocyte nuclear factor 4 gamma (HNF4G), but it is classified as a pseudogene. Pseudogenes are generally considered non-functional by virtue of mutations or lack of expression, and HNF4GP1 itself does not encode a functional protein or contribute directly to biological processes, disease, or drug interactions[4]. There is no evidence it acts as a receptor, enzyme, transporter, transcription factor, or other typical drug target, and it is not referenced in relation to therapeutic development or molecular pathophysiology. If you intended a related but different molecule (such as functional HNF4G, HNF4A, or another member of the HNF4 family), please specify, as only these functional transcription factors are considered conventional drug targets[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte nuclear factor 4 gamma pseudogene 1 (HNF4GP1).